Document Detail


6-Keto-prostaglandin E1: its formation by platelets from prostacyclin and resistance to pulmonary degradation.
MedLine Citation:
PMID:  6348806     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
6-Keto-prostaglandin E1 is a novel biologically active product of the metabolism of prostacyclin in liver and platelets. Further evidence for this bioconversion was obtained in stirred suspensions of platelet rich plasma (PRP) and resuspended platelets (RSP) by sampling and simultaneous assay on a superfusion cascade (rabbit coeliac artery, rat stomach fundus strip) and on human platelet aggregation. Incubation of prostacyclin in saline led to rapid loss of bioactivity (t1/2 3.2 min); its stability was prolonged in platelet poor plasma (t1/2 25.1 min). However, in PRP and RSP a more spasmogenic product was generated transiently. 6-Keto-PGE1, was 3.0 and 2.5 times more potent on the two bioassay tissues, respectively, but approximately 3 times less so as inhibitor of platelet aggregation. 6-Keto-PGE1 is not extensively metabolised in the isolated perfused rat lung (20.4 or 4.2%, depending on protocol), compared with PGE1 (84.3 or 78.5%), and is a much poorer substrate for the principal prostaglandin metabolising enzyme, prostaglandin 15-hydroxydehydrogenase. These data show that 6-keto-PGE1 is a biologically active but pulmonary-resistant product of prostacyclin metabolism but does not resolve the claim that it might have physiological relevance.
Authors:
C N Berry; J R Hoult
Related Documents :
6322546 - Theophylline inhibits platelet aggregation, prostaglandin and thromboxane production by...
4521806 - Isolation and structure of two prostaglandin endoperoxides that cause platelet aggregat...
205256 - Prostaglandin biosynthesis and catabolism in the lamb ductus arteriosus, aorta and pulm...
6247586 - A revised role for cyclic amp in prostaglandin-induced bone resorption.
10753876 - Reactive nitrogen and oxygen species attenuate interleukin- 8-induced neutrophil chemot...
12362226 - The thrombogram in rare inherited coagulation disorders: its relation to clinical bleed...
Publication Detail:
Type:  In Vitro; Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Pharmacology     Volume:  26     ISSN:  0031-7012     ISO Abbreviation:  Pharmacology     Publication Date:  1983  
Date Detail:
Created Date:  1983-09-20     Completed Date:  1983-09-20     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0152016     Medline TA:  Pharmacology     Country:  SWITZERLAND    
Other Details:
Languages:  eng     Pagination:  324-30     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Alprostadil* / analogs & derivatives*
Animals
Blood Platelets / metabolism*
Epoprostenol / metabolism*
Female
Humans
Lung / metabolism*
Male
Platelet Aggregation / drug effects
Prostaglandins / metabolism*
Prostaglandins E / metabolism*,  pharmacology
Rats
Chemical
Reg. No./Substance:
0/Prostaglandins; 0/Prostaglandins E; 35121-78-9/Epoprostenol; 67786-53-2/6-ketoprostaglandin E1; 745-65-3/Alprostadil

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Reduced urinary excretion of prostaglandin E in essential hypertension.
Next Document:  Development of neuromuscular synapses.